Home » NABCOP Gannon MR, Dodwell D, Aggarwal A, Park MH, Miller K, Horgan K, et al. Br J Cancer 2023. https://doi.org/10.1038/s41416-023-02439-z Abstract: Background Multiple drug treatments are approved for invasive breast cancer (IBC). We investigated uptake of...
Home » Publications » Published 2023 » Page 2 P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional treatment in England Amy Zalin-Miller, Sophie Jose, Sophia Le Mare, Betina Blak T...
Home » Publications » Published 2023 » Page 2 Wills, L., Nagarwalla, D., Pearson, C. et al. Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis. Eur J Health...
Home » Publications » Published 2023 » Page 2 Mahmoudpour SH, Knott CS, Amin A, Boutmy E, Verpillat P. Integration of Immuno-oncology (IO) Treatments into Routine Clinical Practice for the Treatment of Patients with Advanced or Metastatic Cancers: Analysis of the...
Home » Archives for Rosemarie Gant » Page 15 Goulden S, Heffernan K, Sen Nikitas F, et al. Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration...